Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
44%
OVERLAP
BY WEIGHT
27
# OF OVERLAPPING
HOLDINGS
IBB
251
HOLDINGS
13%
ALSO IN FBT
FBT
31
HOLDINGS
90%
ALSO IN IBB
SECTOR DRIFT (IBB minus FBT)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 6.3% | 4.0% | 4.0% |
|
AMGEN INC | 8.5% | 3.7% | 3.7% |
|
GILEAD SCIENCES INC | 9.0% | 3.7% | 3.7% |
 |
ARGENX SE ADR | 3.6% | 3.7% | 3.6% |
|
VERTEX PHARMACEUTICALS INC | 8.0% | 3.6% | 3.6% |
IBB Overweight Relative to FBT
|
MODERNA, INC. | 6.5% |
|
GILEAD SCIENCES INC | 5.4% |
|
AMGEN INC | 4.8% |
|
VERTEX PHARMACEUTICALS INC | 4.4% |
|
REVOLUTION MEDICINES, INC. | 2.6% |
|
REGENERON PHARMACEUTICALS | 2.3% |
|
INSMED INC | 1.7% |
 |
ROIVANT SCIENCES LTD. | 1.4% |
|
CHARLES RIVER LABORATORIES | 1.1% |
|
MEDPACE HOLDINGS, INC. | 1.0% |
IBB Underweight Relative to FBT
|
ADMA BIOLOGICS, INC. | -3.9% |
|
TG THERAPEUTICS INC | -3.6% |
|
NEOGENOMICS INC | -3.4% |
 |
ALKERMES PLC | -3.2% |
|
BRUKER CORP | -3.0% |
|
TARSUS PHARMACEUTICALS, INC. | -2.9% |
 |
GENMAB A/S SPONSORED ADR | -2.7% |
|
EXELIXIS INC | -2.7% |
|
NEUROCRINE BIOSCIENCES INC | -2.7% |
|
BIOMARIN PHARMACEUTICAL INC | -2.7% |